This transition is exciting—it creates a motivator for dynamic growth opportunities that underscore medical affairs’ importance to pharma companies.
Online PR News – 27-October-2009 – – Medical affairs plays an instrumental role in providing medical and scientific perspectives for a company’s brands. While the function has long been considered vital, recent years have brought tremendous change. Pressure to remain compliant and increasing globalization have had a profound impact on companies’ medical affairs structures, budgets and strategies. This transition is exciting—it creates a motivator for dynamic growth opportunities that underscore medical affairs’ importance to pharma companies. At the same time, such growth spurs new challenges. Medical affairs teams often struggle to strike a balance— between serving both internal and external customers, as well as being faithful to clinical truths and contributing to commercial goals. Cutting Edge Information’s report Medical Affairs: Delivering Strategic Value addresses the major trends of the medical affairs landscape. It benchmarks industry-leading medical affairs structures and explores best practices departments have implemented to remain compliant with regulatory guidelines. The report provides medical affairs departments with the tools to improve their functions by comparing their spending, staffing, global structures, and strategies to those of top pharmaceutical companies.
The report makes its case with metrics and techniques for managing medical affairs in these key areas:
* Structure, Communication and Globalization - Learn how and why pharmaceutical companies are restructuring their medical affairs departments. Explore department best practices in achieving optimal communication and coordination. Discover how medical affairs is growing globally.
* Budget, Staffing and Success Measurements - Examine top companies’ 2008 medical affairs budgets and staffing by activity. Discover what measures medical affairs departments use to gauge success.
* Strategy, Activities and Compliance - Explore medical affairs’ involvement in strategy-setting, as well as some of the major activities the function is responsible for. Understand how compliance has affected medical affairs today.
Table of Contents :
The following excerpt comes from Chapter 1: “Structuring Efficient Medical Affairs Departments.” The full report contains additional details regarding companies’ medical affairs structural transitions and reporting relationships.
A Time of Transition: Medical Affairs Reorganization
A large trend in the pharmaceutical medical affairs space is the reorganization or realignment of medical affairs departments and groups. Such realignment signifies a shift away from the commercial side and a movement toward greater alignment under the clinical and scientific umbrella. To analyze this change quantitatively, Cutting Edge Information asked surveyed respondents to whom their medical affairs departments reported in 2002 and as well as to whom they report in 2008.
Several companies have maintained their previous reporting relationships — mostly those companies that had reported to departments other than commercial, before maintaining compliance became a larger focus. Figure 1.4 illustrates the number of companies that reported to the major functions of the organization — in 2002, 43% of companies’ medical affairs departments reported to the commercial/marketing side of the organization. By 2008, surveyed companies report a notable difference in reporting relationships…
The following is excerpted from Chapter 2: “Resourcing and Staffing”
Demonstrate Value of Medical Affairs Activities when Requesting Funding
Like any other function or department, medical affairs teams must demonstrate the value of their activities to the company in order to obtain the funding they need. Unlike marketing and commercial operations — which are able tie the value of their activities to easily measurable market results — medical affairs groups must persuade upper management of their worth in other ways. The number and type of medical publications produced over the year, for instance, is one measure of medical affairs productivity, if not of the end value that the activity brings to the company. While very few medical affairs departments have a method for formally measuring and demonstrating ROI, many have come to recognize that, when requesting funding from upper management, a clear, decisive plan of action (POA) goes a long way in winning management buy-in. In fact, the majority medical affairs departments in this study develop some form of POA to help demonstrate their budget needs and obtain funding…..
For more information, please visit :
Or email us at email@example.com or call +919272852585